AstraZeneca PLC ADR (AZNN)

1,139.23
-30.22(-2.58%)
  • Volume:
    26,623
  • Bid/Ask:
    1,135.03/1,160.00
  • Day's Range:
    1,134.61 - 1,162.49
  • Type:Equity
  • Market:Mexico
  • ISIN:US0463531089
  • S/N:046353108

AZNN Overview

Prev. Close
1,170
Day's Range
1,134.61-1,162.49
Revenue
559.63B
Open
1,134.61
52 wk Range
961-1,310
EPS
-
Volume
26,623
Market Cap
3.55T
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,026
P/E Ratio
-
Beta
-
1-Year Change
-8.15%
Shares Outstanding
1,549,116,129
Next Earnings Date
-
What is your sentiment on AstraZeneca PLC ADR?
or
Market is currently closed. Voting is open during market hours.

AstraZeneca PLC ADR News

AstraZeneca PLC ADR Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Buy
Technical IndicatorsSellStrong SellStrong SellStrong SellBuy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy

AstraZeneca PLC ADR Company Profile

AstraZeneca PLC ADR Company Profile

Employees
76100

AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. The company’s marketed products include Tagrisso, Lynparza, Imfinzi, Enhertu, Koselugo, Lumoxiti, Equidacent, Zoladex, Faslodex, Iressa, Arimidex, Casodex/Cosudex, and others for oncology diseases; Onglyza, Bydureon, Lokelma, Byetta, Qtern, Symlin, and others for cardiovascular, renal, and metabolism diseases; and Symbicort, Pulmicort, Fasenra, Daliresp/Daxas, Duaklir, Tudorza/Eklira, Bevespi, Breztri, Anifrolumab, and others for respiratory and immunology diseases. It also offers other medicines and COVID-19 products, including Synagis, Fluenz Tetra/FluMist Quadrivalent, Seroquel IR/Seroquel XR, Vimovo, Movantik/Moventig, Nexium, Losec/Prilosec, and COVID-19 Vaccine AstraZeneca. The company serves primary care and specialty care physicians through distributors and local representative offices. It has a collaboration agreement with Daiichi Sankyo to develop and commercialize DS-1062 for the treatment of trophoblast cell-surface antigen 2 (TROP2) tumor; AliveCor, Inc. to develop non-invasive potassium monitoring solutions; Massachusetts General Hospital to accelerate digital health solutions; Sanguina on smartphone application study for hemoglobin management in patients with anemia of chronic kidney disease; Alchemab to enhance prostate cancer research; and Proteros biostructures GmbH to discover and develop novel small molecules for the treatment of various types of cancer. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Read More
  • Thanks you AstraZ. Bullish. management services.
    0
    • 54 to 64 bullish sentiments again volatility trading
      0
      • $68 in 1 month
        4
        • Do you this will grow as EU has approved their Covid vaccine?
          0
          • will reach 100 in 6 months time
            0
            • I think the vaccine is nothing next to the antibody coctail, known as AZD7442 that Astra is working on at the momenthttps://www.reuters.com/article/health-coronavirus-astrazeneca-antibody-idUSKBN28100E
              0
              • Good buy in the long term.
                1
                • https://www.wsj.com/articles/astrazeneca-agrees-to-buy-alexion-for-39-billion-11607778687?redirect=amp#click=https://t.co/EeYlRyEn3g
                  0
                  • I expect it to reach $ 100 next month
                    1
                    • for super rich returns
                      0
                      • u need to hold it for a long term
                        0
                        • Attention , one of the trial subjects had serious implications , follow the news.
                          1
                          • AstraZeneca will be the best vaccine
                            0
                            • AZN are months ahead of their rivals - we’ll have a vaccine by October.
                              1
                              • Sinovac already had vaccine long before Moderna. But Moderna and Astrazenica have better global distribution...
                                0
                                • Interesting
                                  0
                                  • first Moderna second AstraZeneca to provide vaccine in short time
                                    2
                                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.